Poly Medicure Limited (POLYMED) Share Analysis
NSE · Healthcare · Healthcare
Poly Medicure Limited (NSE: POLYMED) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 14 Nov 2026, the share price was ₹1,681.00, P/E 53.9, ROE 9.8%.
Get the AI verdict on POLYMED: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
POLYMED chart with trendlines
Is POLYMED a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Poly Medicure Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
POLYMED key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,681.00 |
| Market cap | ₹17,041 Cr |
| P/E ratio | 53.9 |
| P/B ratio | 5.22 |
| EPS | ₹31.42 |
| Book value per share | ₹322.00 |
| Dividend yield | 0.21% |
| 52-week range | |
| 52-week high | ₹2,024.00 |
| 52-week low | ₹1,182.00 |
| Face value | ₹5.00 |
| Shareholding pattern | |
| Promoters | 62.41% |
| FIIs | 5.36% |
| DIIs | 15.9% |
| Public | 16.33% |
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.